Immune pathogenesis of hepatocellular carcinoma

Journal of Experimental Medicine

Volumn 188, Issue 2, 1998, Pages 341-350

  Nakamoto, Yasunari ^a   Guidotti, Luca G ^a   Kuhlen, Christian V ^a   Fowler, Patricia ^a   Chisari, Francis V ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Chronic hepatitis; Cytotoxic T lymphocytes; Hepatitis B virus; Hepatocellular carcinoma; Transgenic mice

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; GENE INSERTION; GENOTOXICITY; HEPATITIS B; IMMUNOPATHOGENESIS; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRUS REACTIVATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; LIVER; LIVER NEOPLASMS; MALE; MICE; MICE, TRANSGENIC; T-LYMPHOCYTES, CYTOTOXIC; THYMECTOMY;

EID: 0031872341     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.2.341     Document Type: Article

References (54)

1. Chisari, F.V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29-60.
2. Tsai, S.L., P.J. Chen, M.Y. Lai, P.M. Yang, J.L. Sung, J.H. Huang, L.H. Hwang, T.H. Chang, and D.S. Chen. 1992. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. J. Clin. Invest. 89:87-96.
3. Colombo, M., R. de Franchis, E. Del Ninno. A. Sangiovanni, C. De Fazio, M. Tommasini, M.F. Donato, A. Piva, V. Di Carlo, and N. Dioguardi. 1991. Hepatocellular carcinoma in Italian patients with cirrhosis. N. Engl. J. Med. 325: 675-680.
4. Okuda, K. 1992. Hepatocellular carcinoma: recent progress. Hepatology. 15:948-963.
5. Ikeda, K., S. Saitoh, I. Koida, Y. Arase, A. Tsubota, K. Chayama, H. Kumada, and M. Kawanishi. 1993. A multi-variate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology. 18:47-53.
6. Tsukuma, H., T. Hiyama, S. Tanaka, M. Nakao, T. Yabuuchi, T. Kitamura, K. Nakanishi, I. Fujimoto, A. Inoue, H. Yamazaki, and T. Kawashima. 1993. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N. Engl. J. Med. 328:1797-1801.
7. Grisham, J.W. 1997. Interspecies comparison of liver carcinogenesis: implications for cancer risk assessment. Carcinogenesis (Oxf.). 18:59-81.
8. Matsubara, K., and T. Tokina. 1990. Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis. Mol. Biol. Med. 7:243-260.
9. Maguire, H.F., J.P. Hoeffler, and A. Siddiqui. 1991. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science. 252:842-844.
10. Kekule, A.S., U. Lauer, L. Weiss, B. Luber, and P.H. Hofschneider. 1993. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature. 361:742-745.
11. Natoli, G., M.L. Avantaggiati, P. Chirillo, A. Costanzo, M. Artini, C. Balsano, and M. Levrero. 1994. Induction of the DNA-bindmg activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX. Mol. Cell. Biol. 14:989-998.
12. Wang, X.W., K. Forrester, H. Yeh, M.A. Feitelson, J.-R. Gu, and C.C. Harris. 1994. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. Natl. Acad. Sci. USA. 91:2230-2234.
13. Koike, K., K. Moriya, S. Iino, H. Yotsuyanagi, Y. Endo, T. Miyamura, and K. Hurokawa. 1994. High level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology. 19:810-819.
14. Hildt, E., G. Saher, V. Bruss, and P.H. Hofschneider. 1996. The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology. 225:235-239.
15. Meyer, M., W.H. Caselmann, V. Schluter, R. Schreck, P.H. Hofschneider, and P.A. Baeuerle. 1992. Hepatitis B virus transactivator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization. EMBO (Eur. Mol. Biol. Organ.) J. 11:2991-3001.
16. Chisari, F.V., C.A. Pinkert, D.R. Milich, P. Filippi, A. McLachlan, R.D. Palmiter, and R.L. Brinster. 1985. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science. 230:1157-1160.
17. Chisari, F.V., P. Filippi, A. McLachlan, D.R. Milich, M. Riggs, S. Lee, R.D. Palmiter, C.A. Pinkert, and R.L. Brinster. 1986. Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J. Virol. 60:880-887.
18. Chisari, F.V., P. Filippi, J. Buras, A. McLachlan, H. Popper, C.A. Pinkert, R.D. Palmiter, and R.L. Brinster. 1987. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Prof. Natl. Acad. Sci. USA. 84:6909-6913.
19. Chisari, F.V., K. Klopchin, T. Moriyama, C. Pasquinelli, H.A. Dunsford, S. Sell, C.A. Pinkert, R.L. Brinster, and R.D. Palmiter. 1989. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell. 59: 1145-1156.
20. Dunsford, H.A., S. Sell, and F.V. Chisari. 1990. Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice. Cancer Res. 50:3400-3407.
21. Pasquinelli, C., K. Bhavani, and F.V. Chisari. 1992. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice. Cancer Res. 52:2823-2829.
22. Hagen, T.M., C. Wehr, S.-N. Huang, J. Curnutte, P. Fowler, V. Martinez, B.N. Ames, and F.V. Chisari. 1994. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA. 91: 12808-12812.
23. Huang, S.-N., and F.V. Chisari. 1995. Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice. Hepatology. 21: 620-626.
24. Wirth, S., L.G. Guidotti, K. Ando, H.J. Schlicht, and F.V. Chisari. 1995. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in HBV envelope transgenic mice. J. Immunol. 154:2504-2515.
25. Moriyama, T., S. Guilhot, K. Klopchin, B. Moss, C.A. Pinkert, R.D. Palmiter, R.L. Brinster, O. Kanagawa, and F.V. Chisari. 1990. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science. 248:361-364.
26. Ando, K., T. Moriyama, L.G. Guidotti, S. Wirth, R.D. Schreiber, H.J. Schlicht, S. Huang, and F.V. Chisari. 1993. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178: 1541-1554.
27. Coligan, J.E., A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober. 1994. Current Protocols in Immunology. John Wiley & Sons, Inc., New York.
28. Guidotti, L.G., T. Ishikawa, M.V. Hobbs, B. Matzke, R. Schreiber, and F.V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 4:25-36.
29. Ando, K., L.G. Guidotti, S. Wirth, T. Ishikawa, G. Missale, T. Moriyama, R.D. Schreiber, H.J. Schlicht, S. Huang, and F.V. Chisari. 1994. Class I restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol. 152:3245-3253.
30. Guidotti, L.G., K. Ando, M.V. Hobbs, T. Ishikawa, R.D. Runkel, R.D. Schreiber, and F.V. Chisari. 1994. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Prof. Natl. Acad. Sci. USA. 91:3764-3768.
31. Gilles, P.N., G. Fey, and F.V. Chisari. 1992. Tumor necrosis factor-alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J. Virol. 66:3955-3960.
32. Franco, A., L.G. Guidotti, M.V. Hobbs, V. Pasquetto, and F.V. Chisari. 1997. Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice. J. Immunol. 159:2001-2008.
33. Alter, H.J. 1988. Transfusion-associated non-A, non-B hepatitis: the first decade. In Viral Hepatitis and Liver Disease. A.J. Zuckerman, editor. Alan R. Liss, New York. 534-542.
34. Lieber, C.S., A. Garro, M.A. Leo, K.M. Mak, and T. Worner. 1986. Alcohol and cancer. Hepatology. 6:1005-1019.
35. Niederau, C., R. Fischer, A. Sonnenberg, W. Stremnmel, H.J. Trampisch, and G. Strohmeyer. 1985. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N. Engl. J. Med. 313:1256-1262.
36. Limmer, J., W.E. Fleig, D. Leupold, R. Bittner, H. Ditschunest, and H.-G. Berger. 1988. Hepatocellular carcinoma in type 1 glycogen storage disease. Hepatology. 8:531-537.
37. Carlson, J., and S. Eriksson. 1985. Chronic "cryptogenic" liver disease and malignant hepatoma in intermediate alpha-1-antitrypsin deficiency identified by a pi 2-specific monoclonal antibody. Scand. J. Gastroenterol. 20:835-841.
38. Eriksson, S., J. Carlson, and R.N. Velez. 1986. Risk of cirrhosis and primary liver cancer in alpha-1-antitrypsin deficiency. N. Engl. J. Med. 314:736-740.
39. Melia, W.M., M.L. Wilkinson, B.C. Portmann, P.J. Johnson, and R. Williams. 1984. Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis. Q. J. Med. 53:391-400.
40. Dolberg, D.S., R. Hollingsworth, M. Hertle, and M.J. Bissell. 1985. Wounding and its role in RSV-mediated tumor formation. Science. 230:676-678.
41. Sieweke, M.H., A.W. Stoker, and M.J. Bissell. 1989. Evaluation of the cocarcinogenic effect of wounding in Rous sarcoma virus tumorigenesis. Cancer Res. 49:6419-6424.
42. Lacey, M., S. Alpert, and D. Hanahan. 1986. Bovine papillomavirus genome elicits skin tumours in transgenic mice. Nature. 322:609-612.
43. Konstantinidis, A., J.B. Smulow, and C. Sonnenschein. 1982. Tumorigenesis at a predetermined oral site after one intraperitoneal injection of N-nitroso-N-methylurea. Science. 216: 1235-1237.
44. Korelitz, B.I. 1983. Carcinoma of the intestinal tract in Crohn's disease: results of a survey conducted by the National Foundation for Ileitis and colitis. Am. J. Gastroenterol. 78:44-46.
45. Collins, R.H. Jr., M. Feldman, and J.S. Fordtran. 1987. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N. Engl. J. Med. 316:1654-1658.
46. D'Argenio, G., V. Cosenza, M. Delle Cave, P. Iovino, N. Delle Valle, G. Lombardi, and G. Mazzacca. 1996. Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. Gastroenterology. 110:1727-1734.
47. Johnson, L.D., L.M. Ausman, P.K. Sehgal, and N.W. King, Jr. 1996. A prospective study of the epidemiology of colitis and colon cancer in cotton-top tamarins (Saguinus oedipus). Gastroenterology. 110:102-115.
48. Locke, J.R., D.E. Hill, and Y. Walzer. 1985. Incidence of squamous cell carcinoma in patients with long-term catheter drainage. J. Urol. 133:1034-1035.
49. Kantor, A.F., P. Hartge, R.N. Hoover, and J.F. Fraumeni, Jr. 1988. Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder. Cancer Res. 48: 3853-3855.
50. Yamamoto, M., H.H. Wu, H. Momose, A. Rademaker, and R. Oyasu. 1992. Marked enhancement of rat urinary bladder carcinogenesis by heat-killed Escherichia coli. Cancer Res. 52: 5329-5333.
51. Kawai, K., M. Yamamoto, S. Kameyama, H. Kawamata, A. Rademaker, and R. Oyasu. 1993. Enhancement of rat urinary bladder tumorigenesis by lipopolysaccharide-induced inflammation. Cancer Res. 53:5172-5175.
52. Kawai, K., H. Kawamata, S. Kemeyama, A. Rademaker, and R. Oyasu. 1994. Persistence of carcinogen-altered cell population in rat urothelium which can be promoted to tumors by chronic inflammatory stimulus. Cancer Res. 54:2630-2632.
53. Dahms, B.B., and F.C. Kothstein. 1984. Barrett's esophagus in children: a consequence of chronic gastroesophageal reflux. Gastroenterology. 86:318-323.
54. Cameron, A.J., B.J. Ott, and W.S. Payne. 1985. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N. Engl. J. Med. 313:857-859.